New drug shows promise for calming Tourette's tics in kids
NCT ID NCT02102698
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study tested a drug called ecopipam in 40 children aged 7 to 17 with Tourette's syndrome. The goal was to see if it could reduce the frequency and severity of their tics (unwanted movements and sounds). The drug works by blocking certain dopamine receptors in the brain. The study is complete and measured tic changes using a standard rating scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOURETTE'S SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Children's Mercy Kansas City
Kansas City, Kansas, 64108, United States
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45228, United States
-
Emory University School Of Medicine
Atlanta, Georgia, 30322, United States
-
North Shore-Long Island Jewish Hosptial
Manhasset, New York, 11030, United States
-
Overlook Hospital
Summit, New Jersey, 07902, United States
-
UCLA
Los Angeles, California, 90024, United States
-
University of Chicago Medical School
Chicago, Illinois, 60637, United States
-
University of South Florida/Rothman Center for Neuropsychiatry
St. Petersburg, Florida, 33701, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Weill Cornell Medical School
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.